Abstract Study Objectives: The long-term effect of continuous positive airway pressure
(CPAP) on health-related quality of life (HRQOL) in patients with high cardiovascular …

Rationale: Randomized controlled trials showed no effect of positive airway pressure (PAP)
therapy for obstructive sleep apnea (OSA) on cardiovascular (CV) risk. However, patient …

Background Previous, largely uncontrolled studies demonstrated the substantial effects of
continuous positive airway pressure ventilation (CPAP) on a variety of physiologic and …

Background CPAP reduces blood pressure (BP) in patients with symptomatic obstructive
sleep apnoea (OSA). Whether the same benefit is present in patients with minimally …

Three recent randomized control trials (RCTs) found that treatment of obstructive sleep
apnea (OSA) with continuous positive airway pressure (CPAP) did not reduce rates of future …

Background Obstructive sleep apnea syndrome (OSAS) has been associated with increased
morbidity and mortality, principally from cardiovascular disease, but the impact of nasal …

Rationale: Obstructive sleep apnea (OSA) is common in patients with coronary artery
disease (CAD), many of whom do not report daytime sleepiness. First-line treatment for …

Rationale: Obstructive sleep apnea (OSA) is linked to increased cardiovascular risk, but the
impact of mild forms of OSA and their treatment on cardiovascular outcomes remains …

Background The effect of obstructive sleep apnoea-hypopnoea as a cardiovascular risk
factor and the potential protective effect of its treatment with continuous positive airway …

Emerging research highlights the complex interrelationships between sleep-disordered
breathing and cardiovascular disease, presenting clinical and research opportunities as well …